A Built-for-Purpose Integrated Histology Program to Support Drug and Biomarker Discovery
A Built-for-Purpose Integrated Histology Program to Support Drug and Biomarker Discovery April 1, 2021 Sponsored content brought to you by Exploratory work needs to be cost effective and data must be generated quickly to support rational target discovery and biomarker identification. Biomarkers are crucial to the development of precision medicine treatments and companion diagnostics. But, in practice, it can be difficult distinguishing between potential therapeutic targets and phenotypic measures of disease. This distinction is particularly important in immuno-oncology applications where it i...